Patents Assigned to SGX Pharmaceuticals, Inc.
  • Patent number: 7452993
    Abstract: The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.
    Type: Grant
    Filed: July 27, 2005
    Date of Patent: November 18, 2008
    Assignee: SGX Pharmaceuticals, Inc.
    Inventors: William D. Arnold, Andreas Gosberg, Zhe Li, Ruo W. Steensma, Mark E. Wilson
  • Publication number: 20080261921
    Abstract: The present invention provides fused ring heterocycles as kinase modulators, pharmaceutical compositions containing these modulators, and methods of using these modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: April 10, 2008
    Publication date: October 23, 2008
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: Chixu Chen, Brian Eastman, Andreas Gosberg, Stefan N. Gradl, Gavin Hirst, Stephanie Hopkins, Khanh Thi Tuong Nguyen, Richard Pracitto, Paul E. Sprengeler, Ruo W. Steensma
  • Publication number: 20080221119
    Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: February 29, 2008
    Publication date: September 11, 2008
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: William D. Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo W. Steensma, Mark E. Wilson
  • Patent number: 7361764
    Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
    Type: Grant
    Filed: February 27, 2006
    Date of Patent: April 22, 2008
    Assignee: SGX Pharmaceuticals, Inc.
    Inventors: William D. Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo W. Steensma, Mark E. Wilson
  • Patent number: 7361763
    Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
    Type: Grant
    Filed: July 27, 2005
    Date of Patent: April 22, 2008
    Assignee: SGX Pharmaceuticals, Inc.
    Inventors: William D. Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo W. Steensma, Mark E. Wilson
  • Publication number: 20070287711
    Abstract: The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: April 10, 2007
    Publication date: December 13, 2007
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: William Arnold, Pierre Bounaud, Chixu Chen, Brian Eastman, Andreas Gosberg, Stefan Gradl, Stephanie Hopkins, Zhe Li, Ian McDonald, Paul Sprengeler, Ruo Steensma, Mark Wilson
  • Publication number: 20070173488
    Abstract: The present invention provides pyrazolothiazole kinase modulators, methods of treating certain disease states, such as cancer, and pharmaceutical composition thereof.
    Type: Application
    Filed: November 16, 2006
    Publication date: July 26, 2007
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: Pierre-Yves Bounaud, Stephanie Hopkins, Elizabeth Jefferson, Mark Wilson, Melissa Wong, Toufike Kanouni
  • Publication number: 20070117800
    Abstract: The present invention provides novel pyrimidinyl-thiophene kinase modulators and methods of using the novel pyrimidinyl-thiophene kinase modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: November 2, 2006
    Publication date: May 24, 2007
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: William Arnold, Chixu Chen, Stefan Gradl, Stephanie Hopkins, Ruo Steensma, Masaki Tomimoto, Mark Wilson
  • Publication number: 20070043068
    Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: February 27, 2006
    Publication date: February 22, 2007
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: William Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo Steensma, Mark Wilson
  • Publication number: 20060030583
    Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: July 27, 2005
    Publication date: February 9, 2006
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: William Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo Steensma, Mark Wilson